CTXR
NASDAQ · Pharmaceuticals
Citius Pharmaceuticals Inc
$0.56
-0.01 (-1.65%)
Open$0.57
Previous Close$0.57
Day High$0.60
Day Low$0.55
52W High$2.48
52W Low$0.48
Volume—
Avg Volume290.7K
Market Cap15.00M
P/E Ratio—
EPS$-2.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+587.5% upside
Current
$0.56
$0.56
Target
$3.85
$3.85
$3.27
$3.85 avg
$6.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.36M | 3.56M | 3.14M |
| Net Income | 635.6K | 690.8K | 743.5K |
| Profit Margin | 18.9% | 19.4% | 23.7% |
| EBITDA | 1.24M | 1.20M | 1.26M |
| Free Cash Flow | 627.5K | 529.6K | 500.9K |
| Rev Growth | -2.5% | +1.7% | -0.7% |
| Debt/Equity | 1.45 | 1.39 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |